FDA Inspection 993871 — Liberty Pharma Inc.

Liberty Pharma Inc. — FEI 3010822741

The FDA completed an inspection of Liberty Pharma Inc. on Dec 9, 2016 in Liberty, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liberty, MO (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented